South Africa Radiopharmaceuticals Market to 2032
Overview
The South Africa Radiopharmaceuticals Market is expected to reach a 371.75 USD Billion by 2032 and is projected to grow at a CAGR of 10.16% from 2025 to 2032.
Revenue, 2024 (USD Billion)
216.69
Forecast, 2032 (USD Billion)
371.75
CAGR, 2024 - 2032
10.16%
Report Coverage
South Africa
South Africa Radiopharmaceuticals Market 2018-2032 USD Billion
South Africa Radiopharmaceuticals Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 216.69 USD Billion
- Projected Market Size (2032): 371.75 USD Billion
- CAGR (2025-2032): 10.16%
Key Findings of South Africa Radiopharmaceuticals Market
- The South Africa Radiopharmaceuticals Market was valued at 216.69 USD Billion in 2024.
- The South Africa Radiopharmaceuticals Market is likely to grow at a CAGR of 10.16% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Nuclear Reactors in By Source Segment accounted for the largest share of the market with a revenue of 131.44 USD Billion
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 10.84% during the forecast period from 2024 to 2032.
South Africa Radiopharmaceuticals Market Scope
South Africa Radiopharmaceuticals Market Segmentation & Scope
End User
- Others
- Ambulatory Surgical Centers
- Cancer Research Institutes
- Diagnostic Centers
- Hospitals
By Type
- Therapeutic Radiopharmaceuticals
- Diagnostic Radiopharmaceuticals
By Application
- Therapeutic
- Diagnostic
By Source
- Cyclotrons
- Nuclear Reactors
South Africa Radiopharmaceuticals Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 216.69 USD Billion |
| Market Value in 2032 | 371.75 USD Billion |
| CAGR (2025-2032) | 10.16% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,By Type,By Application,By Source |
Regional Insights:
-
Leading Market (2024-2032): South Africa, leading in terms of revenue 216.69 USD Billion in 2024
- Key Country: South Africa, leading in terms of revenue with value of 216.69 USD Billion in 2024.
Segments and Scope
-
South Africa Radiopharmaceuticals Market to 2032, By End User
- Hospitals is the largest segment in South Africa Radiopharmaceuticals Market to 2032 with a revenue of 86.24 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in South Africa Radiopharmaceuticals Market to 2032 with a Growth rate of 10.84 % in forecast period 2025-2032.
-
South Africa Radiopharmaceuticals Market to 2032, By By Type
- Diagnostic Radiopharmaceuticals is the largest segment in South Africa Radiopharmaceuticals Market to 2032 with a revenue of 124.65 USD Billion in the year 2024.
- Diagnostic Radiopharmaceuticals is the Fastest growing segment in South Africa Radiopharmaceuticals Market to 2032 with a Growth rate of 10.64 % in forecast period 2025-2032.
-
South Africa Radiopharmaceuticals Market to 2032, By By Application
- Diagnostic is the largest segment in South Africa Radiopharmaceuticals Market to 2032 with a revenue of 118.43 USD Billion in the year 2024.
- Diagnostic is the Fastest growing segment in South Africa Radiopharmaceuticals Market to 2032 with a Growth rate of 10.68 % in forecast period 2025-2032.
-
South Africa Radiopharmaceuticals Market to 2032, By By Source
- Nuclear Reactors is the largest segment in South Africa Radiopharmaceuticals Market to 2032 with a revenue of 131.44 USD Billion in the year 2024.
- Nuclear Reactors is the Fastest growing segment in South Africa Radiopharmaceuticals Market to 2032 with a Growth rate of 10.56 % in forecast period 2025-2032.
South Africa Radiopharmaceuticals Market Company Share Analysis
| Company Name |
|
||
| Cardinal Health | |||
| Advanced Accelerator Applications, A Novartis Company | |||
| GE HealthCare | |||
| Lantheus | |||
| Curium and its affiliates | |||
South Africa Radiopharmaceuticals Market Geographical Sales Distribution, 2018-2032 USD Billion
South Africa Radiopharmaceuticals Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South Africa Radiopharmaceuticals Market is segmented based on Segmentation End User,By Type,By Application,By Source.
South Africa Radiopharmaceuticals Market was valued at USD 216.69(Revenue in USD Billion) in 2021.
South Africa Radiopharmaceuticals Market is projected to grow at a CAGR of 10.16% during the forecast period of 2024 to 2032.
The Nuclear Reactors segment is expected to dominate the South Africa Radiopharmaceuticals Market, holding a largest market share of 131.44 USD Billion in 2024
South Africa Radiopharmaceuticals Market Scope
South Africa Radiopharmaceuticals Market Segmentation & Scope
End User
- Others
- Ambulatory Surgical Centers
- Cancer Research Institutes
- Diagnostic Centers
- Hospitals
By Type
- Therapeutic Radiopharmaceuticals
- Diagnostic Radiopharmaceuticals
By Application
- Therapeutic
- Diagnostic
By Source
- Cyclotrons
- Nuclear Reactors
Frequently Asked Questions
The South Africa Radiopharmaceuticals Market is segmented based on Segmentation End User,By Type,By Application,By Source.
South Africa Radiopharmaceuticals Market was valued at USD 216.69(Revenue in USD Billion) in 2021.
South Africa Radiopharmaceuticals Market is projected to grow at a CAGR of 10.16% during the forecast period of 2024 to 2032.
The estimated market value of the South Africa Radiopharmaceuticals Market for final year is USD 371.75 (USD Billion).
South Africa Radiopharmaceuticals Market Company Profiling
Frequently Asked Questions
The South Africa Radiopharmaceuticals Market is segmented based on Segmentation End User,By Type,By Application,By Source.
South Africa Radiopharmaceuticals Market was valued at USD 216.69(Revenue in USD Billion) in 2021.
South Africa Radiopharmaceuticals Market is projected to grow at a CAGR of 10.16% during the forecast period of 2024 to 2032.
The estimated market value of the South Africa Radiopharmaceuticals Market for final year is USD 371.75 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.